全球全基因组亚硫酸盐测序 (WGBS) 市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球全基因组亚硫酸盐测序 (WGBS) 市场 – 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

全球全基因组亚硫酸盐测序 (WGBS) 市场,按产品和服务(DNA 提取、DNA 碎片、DNA 修复、适配器连接、亚硫酸盐处理、PCR 扩增)、应用(干细胞应用、发育生物学、疾病早期诊断、法医科学)、最终用户(制药和生物技术公司、学术和政府机构、合同研究组织)划分 - 行业趋势和预测到 2029 年。

全基因组亚硫酸盐测序(WGBS)市场

全基因组亚硫酸盐测序 (WGBS) 市场分析和规模

全基因组亚硫酸盐测序是一种下一代测序技术,在高通量 DNA 测序之前使用亚硫酸盐确定单个胞嘧啶的甲基化状态。各种基因的 DNA 甲基化状态可以揭示有关基因调控和转录活动的信息。

Data Bridge Market Research 分析称,全基因组亚硫酸盐测序 (WGBS) 市场预计在 2022 年至 2029 年的预测期内将以健康的复合年增长率增长。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

全基因组亚硫酸盐测序 (WGBS) 市场范围和细分      

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

产品和服务(DNA 提取、DNA 片段化、DNA 修复、接头连接、亚硫酸盐处理、PCR 扩增)、应用(干细胞应用、发育生物学、疾病早期诊断、法医科学)、最终用户(制药和生物技术公司、学术和政府机构、合同研究组织)

覆盖国家

北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。

涵盖的市场参与者

Illumina, Inc.(美国)、Epigentek Group Inc(美国)、CD Genomics(美国)、Thermo Fisher Scientific, Inc.(美国)、诺禾致源科技有限公司(中国)、PerkinElmer, Inc.(美国)、Promega Corporation(美国)、BGI(中国)、Nebula Genomics(美国)、Agilent Technologies(美国)、Qiagen(德国)、Macrogen Inc.(韩国)、Oxford Nanopore Technologies plc.(英国)、Veritas(美国)

Market Opportunities

  • Rise in genome sequencing

Market Definition

Whole genome bisulfite sequencing (WGBS) is a critical technique in methylome research. Although a number of tools have been developed to address the mapping challenges caused by bisulfite treatment, the most recent tools available have not been evaluated in terms of read mapping performance as well as biological insights in multiple mammals.

Global Whole Genome Bisulfite Sequencing (WGBS) Market Dynamics

Drivers

  • Rise in genome sequencing

Genome sequencing enables genome-wide methylation profiling at the single-base level which provides methylation status of every CpG locus including partial methylation domains, gene deserts, remote regulatory elements, others which reveals methylation sequence background and reveals absolute DNA methylation levels. During the forecast period of 2022–2029, these factors are boosting the growth of the whole genome bisulfite sequencing (WGBS) market.

  • Rising applications of whole genome sequencing

Single nucleotide resolution methylation profiling at CG, CHG, and CHH sites. differentially methylated sites linked to experimental treatments or sample conditions, understanding cell differentiation or tissue development mechanisms using methylation profiles and early disease and cancer detection by detecting DNA hypermethylation or hypomethylation. These all are the applications of whole genome sequencing which boost the growth of the market.

Opportunities

  • Rising advanced techniques

The increasing number of research and development activities, as well as the adoption of advanced techniques. For instance, whole genome bisulfite sequencing (WGBS) detects methylated cytosines by pre-sequencing the DNA with sodium bisulfite. WGBS has established itself as the gold standard for studying genome-wide methylation at single base resolution. These will provide various opportunities for the growth of the whole genome bisulfite sequencing (WGBS) market during the forecast period.

Restraints/Challenges

  • Low coverage of whole genome bisulfite sequencing

The use of whole genome bisulfite sequencing has been hampered primarily by its high cost, complex data output, and low required coverage. Many studies using whole genome bisulfite sequencing assays have few or no biological replicates due to the high amount and subsequent cost of DNA input. Bisulfite converts unmethylated cytosines to thymidines, reducing sequence complexity, which can make it difficult to create alignments.

这份全基因组亚硫酸盐测序 (WGBS) 市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关全基因组亚硫酸盐测序 (WGBS) 市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

全球全基因组亚硫酸盐测序 (WGBS) 市场范围

全基因组亚硫酸盐测序 (WGBS) 市场根据产品和服务、应用和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

产品与服务

  • DNA提取
  • DNA碎片
  • DNA修复
  • 接头连接
  • 亚硫酸盐处理
  • PCR 扩增

 应用

  • 干细胞应用
  • 发育生物学
  • 疾病早期诊断
  • 法医学

 最终用户

  • 制药和生物技术公司
  • 学术和政府机构
  • 合同研究组织

全基因组亚硫酸盐测序 (WGBS) 市场区域分析/见解

对全基因组亚硫酸盐测序 (WGBS) 市场进行了分析,并按国家、产品和服务、应用和最终用户提供了市场规模洞察和趋势,如上所述。

全基因组亚硫酸盐测序(WGBS)市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区(APAC)的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲(MEA)的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于医疗保健行业发展的投资水平不断飙升以及新技术的增长,北美占据了全基因组亚硫酸盐测序 (WGBS) 市场的主导地位。

由于患糖尿病的人口数量不断增加,预计亚太地区在 2022 年至 2029 年的预测期内将以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和全基因组亚硫酸盐测序 (WGBS) 市场份额分析

全基因组亚硫酸盐测序 (WGBS) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全基因组亚硫酸盐测序 (WGBS) 市场的关注有关。

全基因组亚硫酸盐测序 (WGBS) 市场的一些主要参与者包括:

  • Illumina 公司(美国)
  • Epigentek Group Inc(美国)
  • CD Genomics(美国)
  • 赛默飞世尔科技公司(美国)
  • 诺禾致源股份有限公司 (中国)
  • PerkinElmer, Inc.(美国)
  • Promega 公司 (美国)
  • 华大基因(中国)
  • Nebula Genomics(美国)
  • 安捷伦科技(美国)
  • Qiagen (德国)
  • Macrogen Inc. (韩国)
  • 牛津纳米孔技术有限公司(英国)
  • Veritas(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Factors such as increasing number of research and development activities, as well as the adoption of advanced techniques are the major growth driving factors.
Illumina, Inc. (U.S.), Epigentek Group Inc (U.S.), CD Genomics (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Novogene Co., Ltd. (China), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), BGI (China), Nebula Genomics (U.S.), Agilent Technologies (U.S.), Qiagen (Germany), Macrogen Inc. (South korea), Oxford Nanopore Technologies plc. (U.K.), Veritas (U.S.) are the major companies operating in this market.
North America dominates the whole genome bisulfite sequencing (WGBS) market due to the surging levels of investment for the development of the healthcare industry along with the growth of new technologies.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing number of population suffering from diabetes.